Deborah Dowell

14.2k total citations · 8 hit papers
54 papers, 10.0k citations indexed

About

Deborah Dowell is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Deborah Dowell has authored 54 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Public Health, Environmental and Occupational Health, 27 papers in Anesthesiology and Pain Medicine and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Deborah Dowell's work include Opioid Use Disorder Treatment (33 papers), Pain Management and Opioid Use (26 papers) and Reproductive tract infections research (8 papers). Deborah Dowell is often cited by papers focused on Opioid Use Disorder Treatment (33 papers), Pain Management and Opioid Use (26 papers) and Reproductive tract infections research (8 papers). Deborah Dowell collaborates with scholars based in United States, Ireland and United Kingdom. Deborah Dowell's co-authors include Roger Chou, Tamara M. Haegerich, Grant Baldwin, Christopher M. Jones, Kun Zhang, Kathleen Ragan, Gery P. Guy, Jan L. Losby, Randall Young and Michele K. Bohm and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Deborah Dowell

51 papers receiving 9.6k citations

Hit Papers

CDC Guideline for Prescribing Opioids for Chronic Pain—Un... 2016 2026 2019 2022 2016 2016 2017 2022 2016 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
    2016 3.9k citations Deborah Dowell et al. JAMA profile →
  2. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
    2016 2.0k citations Deborah Dowell et al. profile →
  3. Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
    2017 882 citations Gery P. Guy, Kun Zhang et al. MMWR Morbidity and Mortality Weekly Report profile →
  4. CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022
    2022 751 citations Deborah Dowell, Christopher M. Jones et al. profile →
  5. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
    2016 325 citations Deborah Dowell et al. profile →
  6. No Shortcuts to Safer Opioid Prescribing
    2019 260 citations Deborah Dowell et al. profile →
  7. CDC guideline for prescribing opioids for chronic pain
    2016 249 citations Deborah Dowell et al. profile →
  8. Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
    2024 60 citations Deborah Dowell, Jean Y. Ko et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Dowell United States 28 7.4k 4.8k 2.3k 2.1k 1.6k 54 10.0k
Tamara M. Haegerich United States 24 5.9k 0.8× 3.9k 0.8× 1.9k 0.8× 1.7k 0.8× 1.3k 0.8× 35 8.3k
Amy S. B. Bohnert United States 37 5.0k 0.7× 2.6k 0.5× 931 0.4× 1.3k 0.6× 1.5k 0.9× 126 6.8k
Tara Gomes Canada 46 3.4k 0.5× 1.5k 0.3× 1.0k 0.5× 1.4k 0.7× 1.4k 0.8× 363 9.3k
Rose A. Rudd United States 25 4.9k 0.7× 1.8k 0.4× 735 0.3× 1.5k 0.7× 1.0k 0.6× 31 8.0k
Puja Seth United States 34 6.1k 0.8× 1.9k 0.4× 791 0.3× 1.8k 0.9× 764 0.5× 82 9.1k
Suzanne Nielsen Australia 37 3.3k 0.5× 1.4k 0.3× 1.7k 0.7× 929 0.4× 422 0.3× 254 5.5k
David A. Fiellin United States 66 7.5k 1.0× 1.7k 0.3× 1.7k 0.7× 2.4k 1.1× 301 0.2× 378 15.2k
Philip J Wiffen United Kingdom 61 1.5k 0.2× 3.5k 0.7× 4.0k 1.7× 1.8k 0.8× 2.4k 1.5× 165 13.7k
William C. Becker United States 36 3.1k 0.4× 1.5k 0.3× 1.5k 0.7× 1.0k 0.5× 257 0.2× 172 5.2k
Joseph O. Merrill United States 38 3.0k 0.4× 1.5k 0.3× 933 0.4× 779 0.4× 406 0.2× 75 5.1k

Countries citing papers authored by Deborah Dowell

Since Specialization
Citations

This map shows the geographic impact of Deborah Dowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dowell more than expected).

Fields of papers citing papers by Deborah Dowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Dowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dowell. The network helps show where Deborah Dowell may publish in the future.

Co-authorship network of co-authors of Deborah Dowell

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Dowell. A scholar is included among the top collaborators of Deborah Dowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Dowell. Deborah Dowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowell, Deborah, et al.. (2025). Why have overdose deaths decreased? Widespread fentanyl saturation and decreased drug use among key drivers. The Lancet Regional Health - Americas. 51. 101226–101226.
2.
Han, Beth, Christopher M. Jones, Nora D. Volkow, et al.. (2025). Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. 82(6). 572–572. 7 indexed citations
3.
Han, Beth, Christopher M. Jones, Emily B. Einstein, Deborah Dowell, & Wilson M. Compton. (2024). Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States. The Journal of Clinical Psychiatry. 85(3). 4 indexed citations
4.
Jiang, Xinyi, Sarah Connolly, Andrea E. Strahan, et al.. (2024). Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment — United States, July 2022–September 2023. MMWR Morbidity and Mortality Weekly Report. 73(26). 594–599. 3 indexed citations
5.
Nataraj, Nisha, Andrea E. Strahan, Gery P. Guy, Jan L. Losby, & Deborah Dowell. (2022). Dose tapering, increases, and discontinuity among patients on long-term high-dose opioid therapy in the United States, 2017–2019. Drug and Alcohol Dependence. 234. 109392–109392. 12 indexed citations
6.
Strahan, Andrea E., Nisha Nataraj, Gery P. Guy, Jan L. Losby, & Deborah Dowell. (2022). Prescription History Among Individuals Dispensed Opioid Prescriptions, 2017–2020. American Journal of Preventive Medicine. 63(1). e35–e37. 1 indexed citations
7.
Moro, Ruth N., Andrew I. Geller, Nina J. Weidle, et al.. (2020). Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016–2017. American Journal of Preventive Medicine. 58(4). 526–535. 14 indexed citations
8.
Geller, Andrew I., Deborah Dowell, Maribeth C. Lovegrove, et al.. (2019). U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016. American Journal of Preventive Medicine. 56(5). 639–647. 21 indexed citations
9.
Dowell, Deborah, Hillary V. Kunins, & Thomas A. Farley. (2013). Opioid Analgesics—Risky Drugs, Not Risky Patients. JAMA. 309(21). 2219–2219. 46 indexed citations
10.
Dowell, Deborah & Thomas A. Farley. (2012). Prevention of non-communicable diseases in New York City. The Lancet. 380(9855). 1787–1789. 15 indexed citations
11.
Bradley, Heather, Lenore Asbel, Kyle T. Bernstein, et al.. (2012). HIV Testing Among Patients Infected with Neisseria gonorrhoeae: STD Surveillance Network, United States, 2009–2010. AIDS and Behavior. 17(3). 1205–1210. 11 indexed citations
12.
Newman, Lori M., Deborah Dowell, Kyle T. Bernstein, et al.. (2012). A Tale of Two Gonorrhea Epidemics: Results from the STD Surveillance Network. Public Health Reports. 127(3). 282–292. 27 indexed citations
13.
Dowell, Deborah & Robert D. Kirkcaldy. (2012). Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis. Sexually Transmitted Infections. 88(8). 589–594. 38 indexed citations
14.
Kirkcaldy, Robert D., Ronald C. Ballard, & Deborah Dowell. (2011). Gonococcal Resistance: Are Cephalosporins Next?. Current Infectious Disease Reports. 13(2). 196–204. 35 indexed citations
15.
Hook, Edward W., et al.. (2009). Primary and secondary syphilis - Jefferson County, Alabama, 2002-2007.. MMWR Morbidity and Mortality Weekly Report. 58(17). 463–467. 24 indexed citations
16.
Dowell, Deborah, et al.. (2009). Honey as a Treatment for Cough in Children. American family physician. 80(2). 120. 1 indexed citations
17.
Dowell, Deborah, Philip M. Polgreen, Susan E. Beekmann, et al.. (2009). Dilemmas in the Management of Syphilis: A Survey of Infectious Diseases Experts. Clinical Infectious Diseases. 49(10). 1526–1529. 30 indexed citations
18.
Graber, Mark A, et al.. (2008). Long-term PPI Therapy and the Risk of Hip Fracture. American family physician. 77(3). 277. 1 indexed citations
19.
Graber, Mark A, et al.. (2008). Fluticasone or Salmeterol Alone vs. Combination Therapy for COPD. American family physician. 77(5). 586. 1 indexed citations
20.
Dowell, Deborah, et al.. (2005). Urban Outpatient Views on Quality and Safety in Primary Care. Healthcare Quarterly. 8(2). suppl 2–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara M. Haegerich Breakdown of academic impact, for papers by Amy S. B. Bohnert Breakdown of academic impact, for papers by Tara Gomes Breakdown of academic impact, for papers by Rose A. Rudd Breakdown of academic impact, for papers by Puja Seth Breakdown of academic impact, for papers by Suzanne Nielsen Breakdown of academic impact, for papers by David A. Fiellin Breakdown of academic impact, for papers by Philip J Wiffen Breakdown of academic impact, for papers by William C. Becker Breakdown of academic impact, for papers by Joseph O. Merrill
Rankless by CCL
2026